A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations
Authors:
- Gisela I. RoblesGRGisela I. Robles
- Devada Singh-FrancoDSDevada Singh-Franco
- Hoytin Lee GhinHGHoytin Lee Ghin
- 1 May 2008
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 30 (5) , 800-812
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States)Cancer Causes & Control, 2006
- An Exploration of Latino Smokers and the Use of Pharmaceutical AidsAmerican Journal of Preventive Medicine, 2006
- The effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial designAddiction, 2006
- Successes and failures of the teachable momentCancer, 2005
- Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropionPreventive Medicine, 2004
- Physiological, psychological, social, and cultural influences on the use of menthol cigarettes among Blacks and HispanicsNicotine & Tobacco Research, 2004
- Does menthol attenuate the effect of bupropion among African American smokers?Addiction, 2003
- Efficacy and Safety of an Over-the-counter Transdermal Nicotine Patch as an Aid for Smoking CessationArchives of Family Medicine, 1998
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991
- Development of a Short Acculturation Scale for HispanicsHispanic Journal of Behavioral Sciences, 1987